# DESCRIPTION

## BACKGROUND

- introduce bone generation and maintenance
- describe role of osteoblasts, osteoclasts, and osteocytes
- discuss hCAP-18 and LL-37
- summarize effects of LL-37 on wound healing
- describe bone formation and remodeling
- highlight need for novel bone-forming cells

## SUMMARY

- introduce monocyte-derived bone-forming cell population
- describe characteristics of cell population
- outline method of producing cell population
- discuss use of cell population for bone generation
- describe method of treatment for bone injury or disease
- summarize composition and administration of monoosteophils

## DETAILED DESCRIPTION

- introduce monoosteophils and methods
- motivate monocytes in wound repair
- examine monocyte response to effectors
- describe LL-37 treated monocyte differentiation
- summarize bone-like nodule formation
- describe in vivo transplantation studies
- motivate culturing monoosteophils in vitro
- describe generating monoosteophils by culturing monocytes
- specify isolation of monocytes from bone marrow or blood
- describe selection methods for monocytes
- define effective amount of LL-37
- describe induction of monocyte differentiation
- characterize monoosteophils as distinct cell type
- compare monoosteophils to other bone forming cells
- describe expression of proteins in monoosteophils
- motivate bone remodeling process
- describe osteoblast differentiation from MSCs
- compare monoosteophils to osteoclasts
- describe environmental niche of monocytes
- motivate circulating monocytes in development and homeostasis
- describe potential of circulating monocytes to differentiate
- compare monoosteophils to MOMC and DCs
- motivate use of monoosteophils in bone repair and reconstruction
- introduce bone graft composition
- describe surgical implantation
- detail cosmetic procedures
- describe reconstructive procedures
- explain bone graft composition generation
- introduce monoosteophils for treating bone injuries
- describe therapeutic composition administration
- detail gene product delivery
- define therapeutically effective amount
- explain factors affecting therapeutically effective amount
- describe biocompatible carrier materials
- detail additional therapeutic compounds
- introduce anti-resorptive medications
- describe bone anabolic agents
- detail RANKL inhibitors and nutrient supplements
- explain autologous and allogenic new bone
- describe immunosuppressive agents
- detail routes of administration
- describe treatment for bone injuries and diseases
- explain pathologic fractures
- detail bone diseases and malformations
- describe treatments harming bone
- introduce monoosteophils for dentistry
- describe method for using monoosteophils with prosthetic devices
- detail prosthetic devices for bone and cartilage grafting
- explain seeding prosthetic devices with monoosteophils
- describe modifications to the invention
- provide examples and references

### Generation of LL-37-Differentiated Bone-Forming Cells (Monoosteophils)

- introduce materials and methods
- describe live cell imaging
- list reagents
- describe monocyte preparation and differentiation
- describe cell lines
- describe flow cytometry
- describe statistical analysis
- describe LL-37-induced monocyte differentiation and survival
- describe BMP-4 and BMP-7 expression
- describe surface and intracellular staining of BMPs
- describe LL-37-differentiated monocyte morphology
- describe time lapse photography
- summarize LL-37-induced monocyte differentiation

### Monoosteophils Induce In Vitro and In Vivo Bone Formation

- introduce additional materials and methods
- describe bone resorption assay
- describe scanning electron microscopy (SEM)
- describe von Kossa staining
- describe in vivo transplantation studies
- describe histological examination
- describe monoosteophils' bone-forming ability in vitro
- describe culture of peripheral-blood monocytes
- describe osteoclast morphology
- describe bone absorption ability of LL-37-differentiated monocytes
- describe SEM analysis of refractile specks
- describe von Kossa staining of osteologic discs
- describe monoosteophils' bone-forming ability in vivo
- describe histologic analysis of transplants

### Monoosteophils are Distinct from Other Related Cell Types

- list reagents
- describe monocyte preparation and differentiation
- detail microscopic observation of differentiated monocytes
- describe phagocytosis assay
- outline cytokine multiplex analysis
- summarize morphology of monoosteophils
- describe surface markers of monoosteophils
- detail cytokine release of monoosteophils
- compare monoosteophils to monocyte-derived osteoclasts
- describe morphology of osteoclasts
- detail surface markers of osteoclasts
- compare cytokine release of monoosteophils and osteoclasts
- compare monoosteophils to mesenchymal stem cells
- describe morphology of mesenchymal stem cells
- detail surface markers of mesenchymal stem cells
- compare bone formation of monoosteophils and mesenchymal stem cells
- introduce name "monoosteophil"
- describe differentiation of monocytes into macrophages and dendritic cells
- compare monoosteophils to monocyte-derived macrophages
- describe morphology of macrophages
- detail phagocytosis of macrophages
- compare cytokine release of monoosteophils and macrophages
- compare monoosteophils to monocyte-derived dendritic cells
- describe morphology of dendritic cells
- detail surface markers of dendritic cells
- summarize distinct characteristics of monoosteophils

